Key facts
- This page summarizes Ph.D. Daniel Billen's Form 4 filing for Aurinia Pharmaceuticals Inc. (AUPH).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 20 May 2022, 16:09.
Ph.D. Daniel Billen - 18 May 2022 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)
- Reporting relationship
- Director
- Issuer ticker
- AUPH
- Reported as of
- 18 May 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 May 2022, 16:09:30 UTC
- Prior SEC filing
- 16 Jun 2021
- Next SEC filing
- 23 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel Billen, Ph.D.
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ph.D. Daniel Billen filed Form 4 for Aurinia Pharmaceuticals Inc. (AUPH) on 20 May 2022.
Change
- Previous filing in this sequence was filed on 16 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AUPH
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +8,733
- Change %
- Price
- $0.000000
- Shares after
- 8,733
- Date
- 18 May 2022
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 8,733
- Exercise price
- Footnotes
- F1
AUPH
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +14,612
- Change %
- Price
- $0.000000
- Shares after
- 14,612
- Date
- 18 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 14,612
- Exercise price
- $11.45
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuers common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant.
Footnote F2
The option vests in twelve equal monthly installments commencing on June 18, 2022.